These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26980761)

  • 21. The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.
    Xu F; You X; Liu F; Shen X; Yao Y; Ye L; Zhang X
    Cancer Lett; 2013 Jun; 333(1):124-32. PubMed ID: 23352642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.
    Cai X; Wang X; Cao C; Gao Y; Zhang S; Yang Z; Liu Y; Zhang X; Zhang W; Ye L
    Cancer Lett; 2018 Feb; 415():11-19. PubMed ID: 29174803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic HBXIP enhances ZEB1 through Sp1 to accelerate breast cancer growth.
    Jiang Y; Wang D; Ren H; Shi Y; Gao Y
    Thorac Cancer; 2018 Dec; 9(12):1664-1670. PubMed ID: 30273966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S14 protein in breast cancer cells: direct evidence of regulation by SREBP-1c, superinduction with progestin, and effects on cell growth.
    Martel PM; Bingham CM; McGraw CJ; Baker CL; Morganelli PM; Meng ML; Armstrong JM; Moncur JT; Kinlaw WB
    Exp Cell Res; 2006 Feb; 312(3):278-88. PubMed ID: 16300755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
    Huang LH; Chung HY; Su HM
    BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
    Weng MS; Ho CT; Ho YS; Lin JK
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oncoprotein HBXIP promotes migration of breast cancer cells via GCN5-mediated microtubule acetylation.
    Li L; Liu B; Zhang X; Ye L
    Biochem Biophys Res Commun; 2015 Mar; 458(3):720-725. PubMed ID: 25686500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.
    Pascual-García M; Rué L; León T; Julve J; Carbó JM; Matalonga J; Auer H; Celada A; Escolà-Gil JC; Steffensen KR; Pérez-Navarro E; Valledor AF
    J Immunol; 2013 Jun; 190(12):6520-32. PubMed ID: 23686490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth.
    Xu FF; Sun HM; Fang RP; Zhang L; Shi H; Wang X; Fu XL; Li XM; Shi XH; Wu Y; Ye K; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2022 Feb; 43(2):429-445. PubMed ID: 33824459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nuclear import of oncoprotein hepatitis B X-interacting protein depends on interacting with c-Fos and phosphorylation of both proteins in breast cancer cells.
    Zhang Y; Zhao Y; Li H; Li Y; Cai X; Shen Y; Shi H; Li L; Liu Q; Zhang X; Ye L
    J Biol Chem; 2013 Jun; 288(26):18961-74. PubMed ID: 23667255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of HBXIP Reduces Cell Proliferation, Migration and Invasion In Vitro, and Tumorigenesis In Vivo in Human Urothelial Carcinoma of the Bladder.
    Li X; Liu S
    Cancer Biother Radiopharm; 2016 Nov; 31(9):311-316. PubMed ID: 27831760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1.
    Cai X; Cao C; Li J; Chen F; Zhang S; Liu B; Zhang W; Zhang X; Ye L
    Oncotarget; 2017 Aug; 8(35):58338-58352. PubMed ID: 28938560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer.
    Zhang S; Wang R; Wang X; Guo X; Du Y; Guo X; Zong X; Zhu C; Zhou X
    J Biol Chem; 2022 Mar; 298(3):101644. PubMed ID: 35093383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A.
    Zhu Z; Zhao X; Zhao L; Yang H; Liu L; Li J; Wu J; Yang F; Huang G; Liu J
    Oncogene; 2016 Mar; 35(11):1399-410. PubMed ID: 26148231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth.
    Wu Y; Wang X; Xu F; Zhang L; Wang T; Fu X; Jin T; Zhang W; Ye L
    Nucleic Acids Res; 2020 May; 48(9):4858-4876. PubMed ID: 32313942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.
    Ma Y; Xu L; Rodriguez-Agudo D; Li X; Heuman DM; Hylemon PB; Pandak WM; Ren S
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1369-79. PubMed ID: 18854425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutrient sensor O-GlcNAc transferase controls cancer lipid metabolism via SREBP-1 regulation.
    Sodi VL; Bacigalupa ZA; Ferrer CM; Lee JV; Gocal WA; Mukhopadhyay D; Wellen KE; Ivan M; Reginato MJ
    Oncogene; 2018 Feb; 37(7):924-934. PubMed ID: 29059153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.
    Hu N; Zhang J; Cui W; Kong G; Zhang S; Yue L; Bai X; Zhang Z; Zhang W; Zhang X; Ye L
    J Biol Chem; 2011 Apr; 286(15):13714-22. PubMed ID: 21343296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
    Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.